Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3069 | 1992 | 38.5 | 66% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
202 | 20434 | CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GLANZMANN THROMBASTHENIA | Author keyword | 73 | 64% | 4% | 72 |
2 | GLANZMANNS THROMBASTHENIA | Author keyword | 41 | 57% | 2% | 49 |
3 | THROMBASTHENIA | Author keyword | 22 | 68% | 1% | 19 |
4 | FIBRINOGEN RECEPTOR | Author keyword | 9 | 44% | 1% | 16 |
5 | ALPHAIIBBETA3 RECEPTOR | Author keyword | 9 | 83% | 0% | 5 |
6 | GPIIB | Author keyword | 7 | 64% | 0% | 7 |
7 | GLANZMANN | Author keyword | 6 | 80% | 0% | 4 |
8 | GPIIB IIIA | Author keyword | 6 | 17% | 2% | 32 |
9 | PATHOPHYSIOL HUMAN MOL GENET | Address | 6 | 43% | 1% | 10 |
10 | ALPHA IIB BETA 3 | Author keyword | 5 | 23% | 1% | 18 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLANZMANN THROMBASTHENIA | 73 | 64% | 4% | 72 | Search GLANZMANN+THROMBASTHENIA | Search GLANZMANN+THROMBASTHENIA |
2 | GLANZMANNS THROMBASTHENIA | 41 | 57% | 2% | 49 | Search GLANZMANNS+THROMBASTHENIA | Search GLANZMANNS+THROMBASTHENIA |
3 | THROMBASTHENIA | 22 | 68% | 1% | 19 | Search THROMBASTHENIA | Search THROMBASTHENIA |
4 | FIBRINOGEN RECEPTOR | 9 | 44% | 1% | 16 | Search FIBRINOGEN+RECEPTOR | Search FIBRINOGEN+RECEPTOR |
5 | ALPHAIIBBETA3 RECEPTOR | 9 | 83% | 0% | 5 | Search ALPHAIIBBETA3+RECEPTOR | Search ALPHAIIBBETA3+RECEPTOR |
6 | GPIIB | 7 | 64% | 0% | 7 | Search GPIIB | Search GPIIB |
7 | GLANZMANN | 6 | 80% | 0% | 4 | Search GLANZMANN | Search GLANZMANN |
8 | GPIIB IIIA | 6 | 17% | 2% | 32 | Search GPIIB+IIIA | Search GPIIB+IIIA |
9 | ALPHA IIB BETA 3 | 5 | 23% | 1% | 18 | Search ALPHA+IIB+BETA+3 | Search ALPHA+IIB+BETA+3 |
10 | OPEN CANALICULAR SYSTEM | 5 | 55% | 0% | 6 | Search OPEN+CANALICULAR+SYSTEM | Search OPEN+CANALICULAR+SYSTEM |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IRAQI JEWISH | 110 | 90% | 2% | 47 |
2 | ARAB POPULATIONS | 65 | 93% | 1% | 25 |
3 | GPIIB IIIA | 58 | 30% | 8% | 164 |
4 | CALCIUM BINDING DOMAIN | 50 | 77% | 2% | 34 |
5 | GLYCOPROTEIN IIB IIIA | 47 | 17% | 13% | 256 |
6 | IIB IIIA COMPLEX | 36 | 27% | 6% | 115 |
7 | FIBRINOGEN BINDING | 28 | 24% | 5% | 102 |
8 | OPEN CANALICULAR SYSTEM | 23 | 62% | 1% | 24 |
9 | MEMBRANE GLYCOPROTEIN IIB | 23 | 40% | 2% | 44 |
10 | GLANZMANNS THROMBASTHENIA | 21 | 32% | 3% | 55 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Glanzmann thrombasthenia | 2006 | 82 | 53 | 62% |
Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models | 2011 | 35 | 97 | 56% |
The GPIIb/IIIa (integrin alpha IIb beta 3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend | 2008 | 131 | 182 | 37% |
Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment | 2012 | 10 | 106 | 70% |
Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment | 2002 | 57 | 70 | 74% |
THE PLATELET MEMBRANE GLYCOPROTEIN-IIB-IIIA COMPLEX | 1988 | 1011 | 105 | 52% |
European working group on clinical cell analysis: Consensus protocol for the flow cytometric characterisation of platelet function | 1998 | 227 | 85 | 32% |
Flow cytometry: A clinical test of platelet function | 1996 | 309 | 116 | 29% |
Glanzmann's thrombasthenia: updated | 2002 | 39 | 44 | 70% |
CLUES FOR UNDERSTANDING THE STRUCTURE AND FUNCTION OF A PROTOTYPIC HUMAN INTEGRIN - THE PLATELET GLYCOPROTEIN IIB/IIIA COMPLEX | 1994 | 142 | 177 | 57% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PATHOPHYSIOL HUMAN MOL GENET | 6 | 43% | 0.5% | 10 |
2 | BLOOD VASC BIOL | 4 | 25% | 0.7% | 13 |
3 | UMR 5533 | 4 | 28% | 0.6% | 11 |
4 | PEDIAT HEMATOL ONCOL NEUROONCOL | 3 | 60% | 0.2% | 3 |
5 | PLATEFORME TECHNOL INNOVAT BIOMED | 1 | 38% | 0.2% | 3 |
6 | URA 1464 CNRS | 1 | 100% | 0.1% | 2 |
7 | VAUGHAN TEACHING HOSP | 1 | 100% | 0.1% | 2 |
8 | AMALIA BIRON THROMBOSIS HEMOSTASIS | 1 | 13% | 0.5% | 9 |
9 | MED MED HEMATOL ONCOL SECT | 1 | 33% | 0.2% | 3 |
10 | UMR 5533 CNRS | 1 | 21% | 0.3% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000201694 | BERNARD SOULIER SYNDROME//MAY HEGGLIN ANOMALY//EPSTEIN SYNDROME |
2 | 0.0000146372 | DISINTEGRIN//DISINTEGRINS//ECHISTATIN |
3 | 0.0000124976 | HUMAN PLATELET//PLATELETS HUMAN//ATPASE CA2 MG2 |
4 | 0.0000108946 | I DOMAIN//LEUKOCYTE BIOL INFLAMMAT PROGRAM//LFA 1 |
5 | 0.0000107702 | EPTIFIBATIDE//TIROFIBAN//ABCIXIMAB |
6 | 0.0000103054 | GLYCOPROTEIN VI//GPVI//CLEC 2 |
7 | 0.0000085729 | SPONTANEOUS PLATELET AGGREGATION//PARTICLE COUNTING METHOD//AGGREGOMETER |
8 | 0.0000084565 | NIPECOTAMIDES//ALPHA THROMBIN BINDING//CYTOSOLIC CA2 INCREASE |
9 | 0.0000079531 | PLATELET SUBSTITUTE//ORG EUROPEAN STUDIES//TWINSSHINJUKU KU |
10 | 0.0000073646 | RESPIRATION PHOSPHORYLATION COUPLING//CLIN PHARMACOL CLIN NEUROSCI//MOUSE PLATELETS |